Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Aug 17.
Published in final edited form as: ACS Chem Biol. 2012 Jul 2;7(8):1345–1350. doi: 10.1021/cb3002733

Profiling the Dynamic Interfaces of Fluorinated Transcription Complexes for Ligand Discovery and Characterization

William C Pomerantz 1, Ningkun Wang 2, Ashley K Lipinski 2, Rurun Wang 1, Tomasz Cierpicki 1,2,3, Anna K Mapp 1,2,*
PMCID: PMC3423543  NIHMSID: NIHMS390938  PMID: 22725662

Abstract

The conformationally dynamic binding surfaces of transcription complexes present a particular challenge for ligand discovery and characterization. In the case of the KIX domain of the master coactivator CBP/p300, few small molecules have been reported that target its two allosterically regulated binding sites despite the important roles that KIX plays in processes ranging from memory formation to hematopoiesis. Taking advantage of the enrichment of aromatic amino acids at protein interfaces, here we show that the incorporation of six 19F-labeled aromatic side chains within the KIX domain enables recapitulation of the differential binding footprints of three natural activator peptides (MLL, c-Myb, and pKID) in complex with KIX and effectively reports on allosteric changes upon binding using 1D NMR spectroscopy. Additionally, the examination of both the previously described KIX protein-protein interaction inhibitor Napthol-ASE-phosphate and newly discovered ligand 1–10 rapidly revealed both the binding sites and the affinities of these small molecules. Significantly, the utility of using fluorinated transcription factors for ligand discovery was demonstrated through a fragment screen leading to a new low molecular weight fragment ligand for CBP/p300,1G7. Aromatic amino acids are enriched at protein-biomolecule interfaces; therefore, this quantitative and facile approach will be broadly useful for studying dynamic transcription complexes and screening campaigns complementing existing biophysical methods for studying these dynamic interfaces.


There is mounting interest in dissecting the architectural features and regulatory mechanisms of transcriptional coactivator complexes due to the role such complexes play in disease pathways and the accompanying desire to target them pharmacologically.13 However, these dynamic interfaces are challenging to study and are often characterized as undruggable. In many instances, transcription complex assembly and function occurs through the interaction of structurally dynamic regions of the constituent proteins, with the resulting allosteric changes upon complex formation informing the function.3,4 A foundational example is the KIX domain of the master coactivator CBP/p300, a domain that is targeted by more than a dozen transcriptional activators, including MLL, CREB, and c-Myb, through two allosteri-cally regulated protein binding sites5 Dysregula-tion of these protein-protein interactions contributes to cancer and neurological disorders,68 prompting characterization of native KIX binding interactions and the resulting structural reorganizations.911 However, standard screening methods have led to a very limited group of molecules that target this flexible protein domain, motivating a reevaluation of both ligand discovery and characterization strategies. 1216

Because side chain reorganization plays an important role in the binding events of KIX and other conformationally dynamic proteins,17 we sought a side-chain-detected method that would be sensitive and facile enough for both characterization and screening purposes.18 The employment of 19F-labeled aromatic amino acids appeared an attractive approach due to the signal sensitivity of 19F (83% as sensitive as 1H), the environmental hypersensitivity of 19F chemical shifts, and lack of background signals leading to simplified 1D-NMR spectra.1921 In addition, aromatic amino acids such as tyrosine are enriched at protein binding interfaces.2223 1D-Protein- observed 19F NMR spectroscopy has been a versatile biochemical tool for studying protein folding and function.1921 In addition, several studies have reported changes in the 19F NMR spectra of proteins in the presence of natural ligands or known drugs;2428 however, concerns have been raised that the unfavorable relaxation properties of fluorine-labeled proteins would prohibit its usage in NMR screening applications.2930 Indeed, there are no reports of 1D 19F NMR spectroscopy of proteins for the characterization of small molecule protein-protein interaction inhibitors and no reports of ligand discovery/screening applications. However, we were encouraged by the fact that many transcription factors possess large regions of structural disorder leading to faster internal motion than many globular proteins.31 We thus hypothesized that incorporation of a small subset of side-chain labeled residues at the dynamic binding surfaces of KIX would enable characterization of native and small molecule complexes with this domain and, most importantly, screening applications to discover new ligands.

As a first step, we tested if 1D 19F NMR spectroscopy could differentiate the binding modes of known peptides targeting the allosterically regulated binding sites within the KIX domain. Aromatic amino acids (Phe, Tyr, and Trp) are highly enriched at protein-protein interfaces,2223 especially for α-helix-protein-interactions such as those that occur along both of the KIX binding sites. Six of the seven aromatic amino acid residues present in KIX play critical roles in the binding behavior and structure of this conformationally dynamic domain (Figure 1a). F612 is in van der Waals contact with natural activator MLL.5 Additionally, three of the five tyrosine residues make some of the most important contacts with endogenous ligands MLL (Y631)9 and the phosphorylated kinase inducible domain of CREB, pKID (Y650, Y658). Y649 is in close proximity to bound pKID.10 The remaining residue, Y640, structurally stabilizes KIX through a cation-pi interaction with R600.32 Tyrosine and phenylalanine were therefore ideal choices as spectroscopic probes for lig-and binding and monitoring long-range structural changes to KIX.

Figure 1.

Figure 1

KIX interacting small molecules and peptides. A) A ribbon diagram of the CBP KIX domain (586–672) is shown in gray (PDB ID: 2AGH). Five tyrosine residues (Y631, Y640, Y649, Y650, Y658) phenylalanine (F612) and tryptophan (W590) are available for substitution with fluorinated variants. Blue side chains were labeled in this study. B) ESI mass spectrogram of a 3FY-KIX sample (19:6:1 ratio, of 3FY-labeled KIX, 94%).

We incorporated 3FY into KIX using an auxotrophic bacterial strain, DL39(DE3). Protein expression conditions were optimized using tyrosine-depleted synthetic media with 3FY (0.05 mg/mL) resulting in >90% 3FY incorporation as judged by mass spectrometry (Fig. 1b). Circular dichroism (CD) and fluorescence polarization (FP) were used to assess the effect of 3FY incorporation on KIX structure and function. The data were consistent with a well-folded 3FY-KIX construct with minimally affected function (Figs. S1, S2).33

19F-NMR resonance dispersion is enhanced by the hypersensitivity of the 19F nucleus to differences in chemical environment provided by protein tertiary structure.21 Consistent with this environmental sensitivity, five well-resolved 3FY resonances with an approximately, 5 ppm difference in chemical shift were observed in the 19F-NMR spectrum at 25 °C (Fig. 2A), with an increase in resonance dispersion at lower temperatures (see Supp. Fig S3). Three of the five 3FY resonances were assigned using Tyr to Phe single point mutations (Y650F, Y658F, and Y640F). The spectra of each KIX mutant was similar to the parent sequence with the exception of one missing resonance per mutant (Fig. 2B, Supp. Fig. S4). A paramagnetic line-broadening agent (Gd-EDTA) was used to assign the remaining two resonances as Y631 and Y649, the most and least solvent-exposed residues, respectively. The resonance at -134.6 ppm was minimally affected (Fig 2C). Protection from broadening is consistent with a solvent inaccessible residue, Y649. In contrast, the resonance at -139.4 ppm experienced a high degree of broadening at 8 mM Gd-EDTA,34 consistent with the surface-exposed residue Y631 (Fig. 2C and Supp Fig. S5).

Figure 2.

Figure 2

Resonance assignment of 3FY-KIX at 25°C a) 19F NMR spectrum of 94% 3F-Y-labeled KIX b) A representative spectrum of a tyrosine to phenylalanine point mutant, Y650F, for resonance assignment. c) 19F NMR spectrum of 3FY-KIX in the presence of 8 mM Gd-EDTA.

With assignments in hand, attention first turned to using 1D 19F-NMR to define interactions between KIX and native ligands and the resulting conformational effects. 19F-NMR binding assays were carried out with the unlabeled variants of the transcriptional activation domain peptides used for FP binding studies (pKID29, MLL15 and c-Myb25).911 Although the NMR structure of pKID-bound KIX reveals direct contact of residues Y658 and Y650 with pKID and that Y649 is in close proximity, amide-observed-1H-15N HSQC experiments show only Y658 exhibiting a significant chemical shift change.35 19F-NMR experiments enabled detection of these side-chain contacts, as Y658, Y650 are significantly perturbed. The resonance for Y649, which is in close proximity to pKID, was also affected, whereas the distal residue Y640 does not show a detectable alteration in chemical shift (Fig. 3B and Supp. Fig. S6). In these experiments both the bound and unbound populations were observed, indicating that ligand binding was in the slow exchange regime (Δδ = 0.2 ppm, kex < 148 s-1), consistent with previous reports.36 Binding of pKID to KIX also allosterically regulates MLL binding5 and 19F-NMR experiments revealed perturbation of the 3FY resonance for Y631 in the MLL site upon pKID binding (Fig. 3B, and Supp. S6) supporting an allosteric effect at this site.

Figure 3.

Figure 3

1D 19F-NMR binding experiments. Left) Binding sites for three natural activators with KIX and small molecule Napthol-ASE-phosphate. Red balls refer to significantly perturbed residues upon binding (PDB IDs: 2AGH, 1KDX) pink indicate significant, but lower levels of chemical shift perturbation. Binding isotherm for Napthol-ASE-phosphate binding of KIX is shown for perturbation of the resonance for Y631. Right) 19F NMR spectra of 3FY-KIX (25–55 HM) in the a) absence and presence of b) pKID, c) c-Myb and d) MLL. Dashed lines indicate position of 3FY resonances for unbound KIX.

Myb and pKID target overlapping but distinct sites on KIX due to their different binding orientations.35 In 19F-NMR experiments with c-Myb, the fluorine resonances for Y658, Y650 and Y631 are the most significantly broadened (intermediate exchange). Binding of c-Myb also allosterically regulates the MLL binding site of KIX,5 and 19F NMR binding studies revealed a perturbation of Y631 (Fig. 3D, Supp. S7). Little effect on the resonances for Y649 and Y640 were observed (Fig. 3C, Supp Fig. S7). In contrast, the resonance for the side-chain of Y649 is strong-ly perturbed upon pKID binding (Δδ = 0.2 ppm) likely due to the close proximity of Y649 to the C-terminal helix of pKID.10 From these results we conclude that even with only five 3FY probes, we are able to distinguish distinct binding footprints for two ligands with overlapping binding sites (Fig. 3).

The second activator binding site of KIX is targeted by the transcriptional activation domain of MLL. The NMR structure of a ternary complex of MLL and c-Myb simultaneously bound to KIX reveals close contact between MLL and the Y631 side chain.9 A 1D 19F-NMR spectrum of KIX in complex with MLL shows that Y631 is the only resonance significantly perturbed, with a second population growing in under the resonance assigned to Y650, indicating binding in the slow/intermediate exchange regime (Fig. 3D, Supp. Fig. S8). A single MLL binding site probe could be limiting for detecting protein-ligand interactions. Therefore, a second binding-site probe was investigated. The aromatic amino acid F612 makes extensive hydrophobic contacts with the side-chains of MLL (e.g. F2852 and V2853).9 We expressed a KIX protein that was singly-labeled at position 612 with 4-fluorophenylalanine (4FF). The appearance of a new shifted resonance at −116.2 ppm upon MLL binding supported the sensitivity of this probe (Supp. Fig. S9). Because c-Myb and pKID each enhance MLL binding allosterically,9 we also examined the F612-containing KIX in complex with these two peptides. Surprisingly, only binding of c-Myb perturbs this 4FF resonance (Supp Figs. S10 and S11). This suggests distinct structural differences conferred upon the binding of each of the peptides underlies the similar binding cooperativity, although further studies will be necessary to fully define this effect. Nonetheless, the F612 to 4FF mutation is clearly a valuable probe for detecting changes in the MLL binding surface and complements the 3FY-containing KIX.

Although 1D 19F-NMR spectroscopy proved to be a sensitive technique for characterizing the relatively large surface area complexes between KIX and its native ligands, it remained an open question if the binding of small molecules ligands, with significantly smaller surface area and weaker binding affinity, could be observed by this method. Therefore we next tested the ability to both detect and quantify the binding interactions for libraries of low molecular weight small molecules to assess the feasibility for screening applications.

We first examined the KIX ligand Naphthol-ASE-phosphate, a PPI inhibitor that blocks formation of the KIX•pKID complex.12 In a 1D 19F-NMR experiment a perturbation of Y631 in the MLL site with a large change in chemical shift (0.2 ppm) was identified. Fast exchange data from small molecule titration (Fig. 3) provided a Kd determination of 115 ± 15 HM, comparable to the reported 90 HM Ki.8 A small but significant change in Y649 near the pKID binding site was also observed.33 In a separate experiment, the fluorine resonance of 4FF at F612 was minimally affected in the presence of Napthol-ASE-phosphate (Δδ < 0.04 ppm, Fig. S13). A large perturbation of the fluorine resonance of Y631 and a small perturbation of resonance Y649 at the pKID site supports the report of Naphthol-ASE-phosphate inhibiting pKID:KIX interactions from a distal binding site.12

We next applied 19F NMR to characterize an entirely new KIX ligand, molecule 1–10 (Figure 4), that was identified via a tethered fragment screen directed at the MLL binding site but had not yet been characterized or reported.37 Due to the format of the screen we anticipated that 1–10 would bind in the MLL site but that the affinity would be modest at best. 19F-NMR confirmed binding of compound 1–10 to the MLL site via perturbation of fluorine resonances of Y631 and F61233 (Fig 4B and Supp. Figs. S14,15). 19F-NMR chemical shift perturbation data from titration of increasing amounts of 1–10 up to 15 eq yielded a Kd of 220 HM ± 50 HM (Fig. 4C). Binding was further confirmed via 1H-15N HSQC NMR (Supp. Fig. S20). Successful analysis of weak binding ligands and a small molecule fragment encouraged us to proceed with applying 19F-NMR as a fragment screening technique, a mode of screening that is gaining increasing attention for developing protein-protein interaction inhibitors and assessing druggability.38

Figure 4.

Figure 4

Discovery and characterization of new small molecule KIX complexes. a) Residues with perturbed chemical shifts upon 1–10 binding are mapped onto KIX in red (PDB ID: 2AGH). b) Binding isotherm for 1–10 with KIX is shown for perturbation of the resonance for Y631. c) Chemical shift perturbations of aryl fluorine resonance from 42 HM 3FY-KIX in the presence of small molecule mixtures or d) molecule 1G7 (500 HM).

Given the small surface area and weak binding propensities of fragment libraries, screens of such molecules represent a particular detection challenge. To assess the sensitivity of 1D 19F-NMR in this format, 3FY-KIX was used in a screen with 50 small molecule fragments (from a rule of 3 compliant commercial library) using mixtures of 10 compounds at concentrations of 500 HM. One mixture, Mix 2, showed a large shift for the resonance for Y631 in the MLL binding site (Fig. 4C). Deconvolution of the mixture identified the pyrrole-substituted benzoic acid, 1G7, as the main contributor to the chemical shift perturbation (Fig. 4D). Initial chemical shift information can be obtained within 5–10 minutes for mixtures of ten compounds, and therefore screening of 50 compounds as well as deconvolution can be carried out rapidly in a single day. Few small molecule KIX ligands have been reported, therefore the identification of a new ligand from this screen highlights the potential for using 1D 19F-NMR of aromatic side chains for both follow-up and initial screening.

In conclusion, we deployed 1D19F-NMR for structurally characterizing and quantifying KIX-ligand interactions by achieving sufficient surface coverage by incorporating five to six 19F NMR nuclei at dynamic protein-protein interaction sites. Our studies led to the discovery of two new small molecule KIX ligands, 1–10 and 1G7 and demonstrated for the first time the utility of 19F protein-observed NMR for screening applications. An added benefit was the sensitive detection of differential modes of protein allostery, a common regulatory mechanism of transcriptional complexes and a useful feature to target for developing selective small molecules.39 The ease of experimental set-up (no solvent suppression), tolerance to a wide-range of buffer conditions, temperature, and speed of data acquisition (chemical shift estimates can be obtained in 5–10 minutes) and F-F NOEs40 enables rapid characterization of protein-ligand complexes ranging from peptides to weak-binding small molecules, extending the utility of 19F NMR of proteins into ligand discovery. Resonance broadening from chemical shift anistropy effects becomes more severe for large proteins (i.e. long correlation times). However, the shorter correlation times observed for proteins with larger stretches of disorder31 including many transcription factors, as well as the introduction of new cryoprobe technology will be enabling for extending these studies to a broader set of transcription factors. This will thus complement existing HSQC assays (SAR by NMR)41 and ligand-observed experiments.29

METHODS

Protein expression and purification of His6-KIX (586–672)

The DNA sequence encoding the KIX domain of mouse CBP (586–672) was cloned into a pRSETB vector incorporating a hexahistidine tag with a short linker fused to the N-terminus of KIX (pRSET-BHIS6KIX, Table S2) for protein expression resulting in a protein with sequence (linker residues are shown in lower case):

mrgshhhhhhgmasGVRKGWHEHVTQDLRSHLVHKLVQAIFPTPDPAALKDRRMENLVAYAKKVEGDMY ESANSRDEYYHLLAEKIYKIQKELEEKRRSRL

KIX was expressed as previously described.42 The His-tagged protein was isolated using Ni-NTA beads (Qiagen) according to the manufacturer’s instruction and eluted with 400 mM imidazole. Final purification was carried out by ion-affinity column chromatography on a Source S column, (GE Healthcare) in 50 mM phosphate buffer, pH 7.2 eluting with increasing concentrations of NaCl (0–0.6 M NaCl). Purified protein solutions were buffer exchanged into 10 mM sodium phosphate, 100 mM NaCl, 10% glycerol 0.01% NP40, pH 6.8, using a PD-10 column (GE-healthcare) and stored at −80 °C.

Protein expression and purification fluorine-labeled-KIX (586–672) proteins

Fluorinated amino acids can be incorporated into KIX by two protocols. Protocol 1 uses the auxo-trophic bacterial cell line DL39(DE3) and was optimized for high label incorporation. Protocol 2 uses small molecule-induced auxotrophy of tryptophan, phenylalanine, and tyrosine by addition of glypho-sate (1 mg/mL). Both methods were adapted from protocols detailed by Frieden et al.33 Protocol 2 can be found in the supporting information.

3F-Y and 4F-F incorporation into KIX using the auxotrophic cell line DL39(DE3)

3FY-KIX

The pRSETBHIS6KIX plasmid (Table S2) and the pRARE plasmid (Novagen) were co-transformed into DL39(DE3) cells and grown overnight in 50 mL cultures of Lennox L. broth (Research Products International) supplemented with ampicillin (100 Hg/mL) and chloramphenicol (34 Hg /mL) at 37 °C, 250 RPM. Two 2 mL aliquots were spun down to remove Lennox L. Broth and resuspended in 100 mL of synthetic media reported by Muchmore et al.43 (referred to here as -Y-media,) containing all 20 amino acids except tyrosine and supplemented with ampicillin (100 Hg /mL) and tyrosine (150 HM). Cells were grown to an O.D. of 0.7–1.0 (37 °C, 250 rpm). The cells were pelleted, washed 1 x with –Y media, and resuspended in 100 mL of -Y media plus 0.05 mg/mL 3-fluorotyrosine (Sigma-Aldrich). The bacteria were left to recover at 37 °C, 250 rpm for 3.5 hrs. Protein expression was induced with 0.5 mM IPTG for 3 h at 250 rpm at 37 °C. The His-tagged protein was purified as described above with protein yields up to 18 mg/L and stored at −80 °C in storage buffer, (10 sodium mM phosphate, 100 mM NaCl, 10% glycerol 0.01% NP40, pH 6.8) or NMR buffer, (20 mM HEPES, 100 mM NaCl, 0.2 mM EDTA, 5% D2O, pH 7.2). Label incorporation percentage was determined using a Q-TOF HPLC-MS (Agilent) with electrospray ionization and ranged from 90–99%

4FF-KIX

4FF-KIX was expressed using Protocol 1 with the following exceptions: DL39(DE3) cells were grown in 460 mL synthetic media reported by Muchmore et al.43 (referred to here as F-media) containing all 20 amino acids except phenylalanine and supplemented with ampicillin (100 Hg/mL) and phenyl-alanine (110 HM). Cells were grown to an O.D. of 1.3, (37 °C, 250 rpm). The cells were pelleted, washed 1 x with –F media, and resuspended in 460 mL of -F media plus 4-fluorophenylalanine (125 HM, Sigma-Aldrich) and a minimal amount of phenylalanine (40 HM). The bacteria were left to recover at 37 °C, 250 rpm for 30 min. Protein expression was induced with 0.5 mM IPTG for 3 h at 250 rpm at 37 °C. The His-tagged protein was purified and characterized as described above. 85% 4FF incorporation.

1D-19F NMR

Parameters used

19F NMR data were acquired at 470 MHz on a Varian 500 spectrometer with a 5 mm PFG OneNMR Probe. Spectra were obtained without proton decoupling. Samples containing 20–55 HM 3FY or 4FF-labeled protein in 20 mM HEPES, 100 mM NaCl, 5% D2O , pH 7.2, were prepared con-taining 50 HM sodium trifluoroacetate as a reference (-76.5 ppm) for binding assays. A T1 value of 0.6 s was obtained by the inversion-recovery method. Measurement parameters included a relaxation delay time of 1 s for small molecules and c-Myb and an acquisition time of 0.3 s. A delay time of 1.5 s and a 0.5 s acquisition time was used in binding experiments with pKID and MLL. All experiments used a 9500 Hz sweep width. 15–20 Hz line-broadening was applied to each spectrum. 1000–2500 transients were taken for each solution unless otherwise stated.

Ligand Binding Studies

Peptides and small molecules were titrated into the protein solution from concentrated stock solutions of DMSO (20 mM for peptides and 100 mM for small molecules). Final DMSO concentrations were kept below 0.5% DMSO. For small molecule titrations 2000 scans were acquired to assure good S/N resolution for improved fitting of the data. However, good chemical shift estimates can be readily acquired at 200–400 scans, 5–10 minutes for initial screening. A pilot fragment screen was carried out using a concentration of 42 HM 3FY-KIX in the presence of a mixture of 10 small molecule fragments with each molecule at 0.5 mM per sample mixture (5% DMSO). Molecule 1G7 was identified by rescreening small molecules as binary mixtures or as a single compound.

Supplementary Material

1_si_001

Acknowledgments

A.K.M. is grateful to the NIH (GM06553) and Novartis (Novartis Young Investigator Award), for support of this work. W.C.P. is thankful to the NIH for a postdoctoral fellowship (F32 GM090550). We thank J. A. Wells and J. Sadowsky for guidance and materials for the fragment tethering screens from which 1-10 was identified. We also kindly thank I. Ropson for providing us with the DL39(DE3) cell line.

Footnotes

ASSOCIATED CONTENT

Supporting information: Additional experimental procedures, tables, figures and characterization data can be accessed free of charge via the internet at http://www.pubs.acs.org.

SUPPORTING INFORMATION

Supporting methods for peptide synthesis, protein expression, spectroscopy, plasmid information, and supporting figures and tables are available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.Koehler AN. A complex task? Direct modulation of transcription factors with small molecules. Curr Opin Chem Biol. 2010;14:331–340. doi: 10.1016/j.cbpa.2010.03.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lee LW, Mapp AK. Transcriptional Switches: Chemical Approaches to Gene Regulation. J Biol Chem. 2010;285:11033–11038. doi: 10.1074/jbc.R109.075044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fuxreiter M, Tompa P, Simon I, Uversky VN, Hansen JC, Asturias FJ. Malleable machines take shape in eukaryotic transcriptional regulation, Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept. Nat Chem Biol. 2008;4:728–37. doi: 10.1038/nchembio.127. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Uversky VN. Expert Rev Proteomics. 2010;7:543–564. doi: 10.1586/epr.10.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol. 2005;6:197–208. doi: 10.1038/nrm1589. [DOI] [PubMed] [Google Scholar]
  • 5.Goto NK, Zor T, Martinez-Yamout M, Dyson HJ, Wright PE. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP) - The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain. J Biol Chem. 2002;277:43168–43174. doi: 10.1074/jbc.M207660200. [DOI] [PubMed] [Google Scholar]
  • 6.Hallam TM, Bourtchouladze R. Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction. Cell Mol Life Sci. 2006;63:1725–1735. doi: 10.1007/s00018-005-5555-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sakamoto KM, Frank DA. CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy. Clin Cancer Res. 2009;15:2583–2587. doi: 10.1158/1078-0432.CCR-08-1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ramirez JA, Nyborg JK. Molecular characterization of HTLV-1 tax interaction with the KIX domain of CBP/p300. J Mol Biol. 2007;372:958–969. doi: 10.1016/j.jmb.2007.06.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.De Guzman RN, Goto NK, Dyson HJ, Wright PE. Structural basis for cooperative transcription factor binding to the CBP coactivator. J Mol Biol. 2006;355:1005–1013. doi: 10.1016/j.jmb.2005.09.059. [DOI] [PubMed] [Google Scholar]
  • 10.Radhakrishnan I, PerezAlvarado GC, Parker D, Dyson HJ, Montminy MR, Wright PE. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: A model for activator:Coactivator interactions. Cell. 1997;91:741–752. doi: 10.1016/s0092-8674(00)80463-8. [DOI] [PubMed] [Google Scholar]
  • 11.Zor T, De Guzman RN, Dyson HJ, Wright PE. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J Mol Biol. 2004;337:521–534. doi: 10.1016/j.jmb.2004.01.038. [DOI] [PubMed] [Google Scholar]
  • 12.Best JL, Amezcua CA, Mayr B, Flechner L, Murawsky CM, Emerson B, Zor T, Gardner KH, Montminy M. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc Natl Acad Sci U S A. 2004;101:17622–17627. doi: 10.1073/pnas.0406374101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bates CA, Pomerantz WC, Mapp AK. Transcriptional Tools: Small Molecules for Modulating CBP KIX–Dependent Transcriptional Activators. Biopolymers. 2011;95:17–23. doi: 10.1002/bip.21548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Li BBX, Xiao XS. Discovery of a Small-Molecule Inhibitor of the KIX-KID Interaction. ChemBioChem. 2009;10:2721–2724. doi: 10.1002/cbic.200900552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Alluri P, Liu B, Yu P, Xiao XS, Kodadek T. Isolation and characterization of coactivator- binding peptoids from a combinatorial library. Mol Biosyst. 2006;2:568–79. doi: 10.1039/b608924k. [DOI] [PubMed] [Google Scholar]
  • 16.Rutledge SE, Volkman HM, Schepartz A. Molecular recognition of protein surfaces: High affinity ligands for the CBPKIX domain. J Am Chem Soc. 2003;125:14336–14347. doi: 10.1021/ja034508o. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.For example see: Bruschweiler S, Schanda P, Kloiber K, Brutscher B, Kontaxis G, Konrat R, Tollinger M. Direct Observation of the Dynamic Process Underlying Allosteric Signal Transmission. J Am Chem Soc. 2009;131:3063–3068. doi: 10.1021/ja809947w.
  • 18.Najmanovich R, Kuttner J, Sobolev V, Edelman M. Side-chain flexibility in proteins upon ligand binding. Proteins. 2000;39:261–268. doi: 10.1002/(sici)1097-0134(20000515)39:3<261::aid-prot90>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  • 19.Hull EW, Sykes BD. Fluorotyrosine alkaline phosphatase: internal mobility of individual tyrosines and the role of chemical shift anisotropy as a 19F nuclear spin relaxation mechanism in proteins. J Mol Biol. 1975;98:121–153. doi: 10.1016/s0022-2836(75)80105-7. [DOI] [PubMed] [Google Scholar]
  • 20.Frieden C, Hoeltzli SD, Bann JG. The preparation of F-19-labeled proteins for NMR studies. Methods Enzymol. 2004;380:400–415. doi: 10.1016/S0076-6879(04)80018-1. [DOI] [PubMed] [Google Scholar]
  • 21.Kitevski-LeBlanc JL, Prosser RS. Current applications of 19F NMR to studies of protein structure and dynamics. Prog Nucl Magn Reson Spectrosc. 2012;62:1–33. doi: 10.1016/j.pnmrs.2011.06.003. [DOI] [PubMed] [Google Scholar]
  • 22.Bogan AA, Thorn KS. Anatomy of hot spots in protein interfaces. J Mol Biol. 1998;280:1–9. doi: 10.1006/jmbi.1998.1843. [DOI] [PubMed] [Google Scholar]
  • 23.Bullock BN, Jochim AL, Arora PS. Assessing Helical Protein Interfaces for Inhibitor Design. J Am Chem Soc. 2011;133:14220–14223. doi: 10.1021/ja206074j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.For examples see references 2428: Salopek-Sondi B, Vaughan MD, Skeels MC, Honek JF, Luck LA. F-19 NMR studies of the leucine-isoleucine-valine binding protein: Evidence that a closed conformation exists in solution. J Biomol Struct Dyn. 2003;21:235–246. doi: 10.1080/07391102.2003.10506919.
  • 25.Hoeltzli SD, Frieden C. 19F NMR spectroscopy of [6-19F]tryptophan-labeled Escherichia coli dihydrofolate reductase: equilibrium folding and ligand binding studies. Biochemistry. 1994;33:5502–5509. doi: 10.1021/bi00184a019. [DOI] [PubMed] [Google Scholar]
  • 26.Evanics F, Kitevski JL, Bezsonova I, Forman-Kay J, Prosser RS. F-19 NMR studies of solvent exposure and peptide binding to an SH3 domain. Biochim Biophys Acta- Gen Subj. 2007;1770:221–230. doi: 10.1016/j.bbagen.2006.10.017. [DOI] [PubMed] [Google Scholar]
  • 27.Liu JJ, Horst R, Katritch V, Stevens RC, Wüthrich K. Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science. 2012;335:1106–1110. doi: 10.1126/science.1215802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cellitti SE, Jones DH, Lagpacan L, Hao XS, Zhang Q, Hu HY, Brittain SM, Brinker A, Caldwell J, Bursulaya B, Spraggon G, Brock A, Ryu Y, Uno T, Schultz PG, Geierstanger BH. In vivo incorporation of unnatural amino acids to probe structure, dynamics, and ligand binding in a large protein by nuclear magnetic resonance spectroscopy. J Am Chem Soc. 2008;130:9268–9281. doi: 10.1021/ja801602q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Dalvit C, Fagerness PE, Hadden DTA, Sarver RW, Stockman BJ. Fluorine-NMR experiments for high-throughput screening: Theoretical aspects, practical considerations, and range of applicability. J Am Chem Soc. 2003;125:7696–7703. doi: 10.1021/ja034646d. [DOI] [PubMed] [Google Scholar]
  • 30.Dalvit C. Ligand- and substrate-based 19F NMR screening: Principles and applications to drug discovery. Prog Nucl Magn Reson Spectrosc. 2007;51:243–271. [Google Scholar]
  • 31.Li C, Charlton LM, Lakkavaram A, Seagle C, Wang G, Young GB, Macdonald JM, Pielak GJ. Differential dynamical effects of macromolecular crowding on an intrinsically disordered protein and a globular protein: Implications, for in-cell NMR spectroscopy. J Am Chem Soc. 2008;130:6310–6311. doi: 10.1021/ja801020z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wei Y, Horng JC, Vendel AC, Raleigh DP, Lumb KJ. Contribution to stability and folding of a buried polar residue at the CARM1 methylation site of the KIX domain of CBP. Biochemistry. 2003;42:7044–7049. doi: 10.1021/bi0343976. [DOI] [PubMed] [Google Scholar]
  • 33.Please see the Supporting Information.
  • 34.Y658 and Y650 are also exposed to solvent and broaden at the highest concentration of gadolinium. Y640 packs against the N-terminal 310 helix of KIX. Similar to Y649, this resonance was also less affected.
  • 35.Zor T, Mayr BM, Dyson HJ, Montminy MR, Wright PE. Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c- Myb) and inducible (CREB) activators. J Biol Chem. 2002;277:42241–42248. doi: 10.1074/jbc.M207361200. [DOI] [PubMed] [Google Scholar]
  • 36.Sugase K, Dyson HJ, Wright PE. Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature. 2007;447:1021–1025. doi: 10.1038/nature05858. [DOI] [PubMed] [Google Scholar]
  • 37.For a discussion of disulfide tethering see, Erlanson DA, Wells JA, Braisted AC. Tethering: fragment-based drug discovery. Annu Rev Biophys Biomolec Struct. 2004;33:199–223. doi: 10.1146/annurev.biophys.33.110502.140409.. Details of the assay format will be discussed in subsequent report
  • 38.Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov. 2007;6:211–219. doi: 10.1038/nrd2220. [DOI] [PubMed] [Google Scholar]
  • 39.Deng XM, Okram B, Ding QA, Zhang JM, Choi YM, Adrian FJ, Wojciechowski A, Zhang GB, Che JW, Bursulaya B, Cowan-Jacob SW, Rummel G, Sim T, Gray NS. Expanding the Diversity of Allosteric Bcr-Abl Inhibitors. J Med Chem. 2010;53:6934–6946. doi: 10.1021/jm100555f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Yu LP, Hajduk PJ, Mack J, Olejniczak ET. Structural studies of Bcl-xL/ligand complexes using F-19 NMR. J Biomol NMR. 2006;34:221–227. doi: 10.1007/s10858-006-0005-y. [DOI] [PubMed] [Google Scholar]
  • 41.Shuker SB, Hajduk PJ, Meadows RP, Fesik SW. Discovering high-affinity ligands for proteins: SAR by NMR. Science. 1996;274:1531–1534. doi: 10.1126/science.274.5292.1531. [DOI] [PubMed] [Google Scholar]
  • 42.Buhrlage SJ, Bates CA, Rowe SP, Minter AR, Brennan BB, Majmudar CY, Wemmer DE, Al-Hashimi H, Mapp AK. Small molecule transcriptional activation domains interact with endogenous coactivators. ACS Chem Biol. 2009;4:335–344. doi: 10.1021/cb900028j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Muchmore DC, McIntosh LP, Russell CB, Anderson DE, Dahlquist FW. Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. Method Enzymol. 1989;177:44–73. doi: 10.1016/0076-6879(89)77005-1. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES